Risk Factors and Outcomes for Patients with Bloodstream Infection Due to Acinetobacter baumannii-calcoaceticus ComplexCHOPRA, Teena; MARCHAIM, Dror; KAYE, Keith S et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4630-4635, issn 0066-4804, 6 p.Article

Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical OutcomesCHOPRA, Teena; MARCHAIM, Dror; AHMED, Harris et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 6270-6275, issn 0066-4804, 6 p.Article

Authorship and Characteristics of Articles in Pharmacy Journals: Changes Over a 20-Year IntervalDOTSON, Bryan; MCMANUS, Kevin P; ZHAO, Jing J et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 3, pp 357-363, issn 1060-0280, 7 p.Article

Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coliCHOPRA, Teena; MARCHAIM, Dror; CHEN, Ting-Yi et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3936-3942, issn 0066-4804, 7 p.Article

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective StudyKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Pharmacotherapy. 2011, Vol 31, Num 6, pp 527-536, issn 0277-0008, 10 p.Article

Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory TestsMARCHAIM, Dror; SUNKARA, Bharath; DHAR, Sorabh et al.Infection control and hospital epidemiology. 2012, Vol 33, Num 8, pp 853-855, issn 0899-823X, 3 p.Article

Epidemiology and outcomes associated with surgical site infection following bariatric surgeryCHOPRA, Teena; MARCHAIM, Dror; ALANGADEN, George et al.American journal of infection control. 2012, Vol 40, Num 9, pp 815-819, issn 0196-6553, 5 p.Article

Automated Alerts Coupled with Antimicrobial Stewardship Intervention Lead to Decreases in Length of Stay in Patients with Gram-Negative BacteremiaPOGUE, Jason M; MYNATT, Ryan P; MARCHAIM, Dror et al.Infection control and hospital epidemiology. 2014, Vol 35, Num 2, pp 132-138, issn 0899-823X, 7 p.Article

Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration > 1 mg/L: A Matched Cohort StudyMURRAY, Kyle P; ZHAO, Jing J; DAVIS, Susan L et al.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1562-1569, issn 1058-4838, 8 p.Article

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal InfectionsCASAPAO, Anthony M; KULLAR, Ravina; COSGROVE, Sara E et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4190-4196, issn 0066-4804, 7 p.Article

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health SystemPOGUE, Jason M; LEE, Jiha; MARCHAIM, Dror et al.Clinical infectious diseases. 2011, Vol 53, Num 9, pp 879-884, issn 1058-4838, 6 p.Article